+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 50Years +
All Genders
ID07473713

Evaluating Veverimer Dosing to Reduce Acid Excretion and Bone Loss in Adults With Osteopenia

Led by Tufts Medical Center · Updated on 2026-10-26

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether veverimer can reduce urinary net acid excretion and bone breakdown in adults aged 50 and older who have osteopenia, a condition where bone density is lower than normal but not low enough to be osteoporosis. This phase 1, prevention-focused clinical trial aims to understand how different doses of veverimer compare to placebo in reducing acid excretion and affecting bone health and physical performance. Participants will be randomly assigned to receive either 9 grams of veverimer daily, 9 grams every other day, or a placebo powder mixed into water for 8 weeks. The study includes 8 clinic visits, including a screening visit, during which participants will take the study powder and keep a diary to track medication use. The trial compares effects on acid excretion, bone resorption and formation, and physical performance. Throughout the study, participants will have urine and blood tests at multiple time points to measure acid levels, serum bicarbonate, potassium, and bone markers. The primary outcome is the change in 24-hour urinary net acid excretion measured at screening, week 2, week 8, and one day after week 8. Safety and other bone-related markers will also be monitored. Participants will be followed for a total of 8 weeks of treatment with regular clinic visits and assessments.

CONDITIONS

Brief Title

Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia

Research Team

E

Elise Danico, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here